{"id":809132,"date":"2025-02-05T08:38:49","date_gmt":"2025-02-05T13:38:49","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/"},"modified":"2025-02-05T08:38:49","modified_gmt":"2025-02-05T13:38:49","slug":"lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/","title":{"rendered":"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BASKING RIDGE, N.J., Feb.  05, 2025  (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present a corporate overview at the 2025 BIO CEO &amp; Investor Conference taking place February 10-11, 2025 at the New York Marriott Marquis in New York City.<\/p>\n<p>Dr. Mazzo\u2019s presentation is scheduled for Monday, February 10<sup>th<\/sup> at 2:00 p.m. Eastern Time. For more information about the conference and how to register, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ecLdwqJynXO87RWwXNbZP3ji-ZpSYrr8UjYU-8685BhhINdpCdIANyXTF6HNlNhEJTllL81WId6QLwKUPWWsi_RV_kPJVNSRMw312LfiuZwHPunmmKl04SD4HK6SMLJB\" rel=\"nofollow\" target=\"_blank\"><u>https:\/\/bcic.bio.org\/registration<\/u><\/a>.<\/p>\n<p>\n        <strong>About Lisata Therapeutics<\/strong>\n      <\/p>\n<p>Lisata Therapeutics is a <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=I7uMuCcHD8WAjb1KCDXhmD3rR2pcRuE3C9oyUoGiMY8MZn4z_yCFUQNND3g4sd8Dvy8r6NAKmzXz9P73SWUp1TjkiQ7y-mUeR4k6AsgQsPB9yOv-eLzE5d_3BMnox5FomL8y3Shoz1862dCwYVkOj4uoH6ITSIU-M713uVwRVv0=\" rel=\"nofollow\" target=\"_blank\"><u>clinical-stage pharmaceutical company<\/u><\/a> dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Lisata\u2019s cyclic peptide product candidate, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pwtHZQarU-nwlm9uKzP6tRFLixPG81UaRFG_5Gk4x-4VLvYNzdTdWZkfc0NlI4OKVsH6xdwiHfI60aTPuQXshQBdmHDt0B9dNWeEms-N95m2Oi2ivQzOyRaqlhXMfiAqnIixUeDevZRDyN1Gb8GrofL7Uv74tvWCp0aG9uSR2lf7yc6sDuW_3V1vN35BynYs\" rel=\"nofollow\" target=\"_blank\"><u>certepetide<\/u><\/a>, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to selectively target and penetrate solid tumors more effectively. Lisata has already established noteworthy commercial and R&amp;D partnerships based on its <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=knkPOh8DcF7ReqO1SsEOaYGy1qri13NZvQAKRTRQhSqYpb0eZ4Gd4Y02VLFmgzECAqJSmnAJcVJuMyfhipfEBnJsGZ8cf-CeUYJwLpZl8QZTFm7ZXDCtq5_Icfd8F0BumGVS7APr0zt44axkC7tcWA==\" rel=\"nofollow\" target=\"_blank\"><u>CendR Platform<sup>\u00ae<\/sup> technology<\/u><\/a>. The Company expects to announce numerous milestones over the next 1.5 years and believes that its projected capital will fund operations into early 2026, encompassing anticipated data milestones from its ongoing and planned clinical trials. Learn more about <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pwtHZQarU-nwlm9uKzP6tQAoTRYpD41BE9QePsRclpPNQzM9kWZD0dIc2TOfEV17en4xBqqP13opS6fEM_qwh2XdIhBm5fU49bhUwsma__obxitr_MzN9Wp7iVZJnDIz5oYB4CkPThsLo0_-aSTTk7zewxn8mDk0DlZ2DXoRlRM=\" rel=\"nofollow\" target=\"_blank\"><u>certepetide\u2019s mechanism of action in our short film<\/u><\/a>. For more information on the Company, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FOoOam7IuopNSmuUQHoSginBttquzNF4q4YvdKB-ExrzCYqKW5NMJCBroDGvbdhArOqRW2coiOl_esKN9stssA==\" rel=\"nofollow\" target=\"_blank\"><u>www.lisata.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>Investors:<br \/>Lisata Therapeutics<br \/>John Menditto<br \/>Vice President, Investor Relations and Corporate Communications<br \/>Phone:\u00a0908-842-0084<br \/>Email:\u00a0jmenditto@lisata.com<\/p>\n<p>Media:<br \/>ICR Healthcare<br \/>Elizabeth Coleman<br \/>Account Supervisor<br \/>Phone: 203-682-4783<br \/>Email: elizabeth.coleman@icrhealthcare.com<\/p>\n<p>This press release was published by a CLEAR\u00ae Verified individual.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NmE5MTNkYzQtZjZkNi00MDVmLTk2MTYtNmViYjkwY2RlYWQ2LTEwMzI4NjY=\/tiny\/Lisata-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BASKING RIDGE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present a corporate overview at the 2025 BIO CEO &amp; Investor Conference taking place February 10-11, 2025 at the New York Marriott Marquis in New York City. Dr. Mazzo\u2019s presentation is scheduled for Monday, February 10th at 2:00 p.m. Eastern Time. For more information about the conference and how to register, please visit https:\/\/bcic.bio.org\/registration. About Lisata Therapeutics Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-809132","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BASKING RIDGE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present a corporate overview at the 2025 BIO CEO &amp; Investor Conference taking place February 10-11, 2025 at the New York Marriott Marquis in New York City. Dr. Mazzo\u2019s presentation is scheduled for Monday, February 10th at 2:00 p.m. Eastern Time. For more information about the conference and how to register, please visit https:\/\/bcic.bio.org\/registration. About Lisata Therapeutics Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development &hellip; Continue reading &quot;Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T13:38:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference\",\"datePublished\":\"2025-02-05T13:38:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/\"},\"wordCount\":295,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/\",\"name\":\"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=\",\"datePublished\":\"2025-02-05T13:38:49+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference - Market Newsdesk","og_description":"BASKING RIDGE, N.J., Feb. 05, 2025 (GLOBE NEWSWIRE) &#8212; Lisata Therapeutics, Inc. (Nasdaq: LSTA) (\u201cLisata\u201d or the \u201cCompany\u201d), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will present a corporate overview at the 2025 BIO CEO &amp; Investor Conference taking place February 10-11, 2025 at the New York Marriott Marquis in New York City. Dr. Mazzo\u2019s presentation is scheduled for Monday, February 10th at 2:00 p.m. Eastern Time. For more information about the conference and how to register, please visit https:\/\/bcic.bio.org\/registration. About Lisata Therapeutics Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development &hellip; Continue reading \"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-05T13:38:49+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference","datePublished":"2025-02-05T13:38:49+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/"},"wordCount":295,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/","name":"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=","datePublished":"2025-02-05T13:38:49+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM1MzI3MSM2NzM2NDY5IzIwMjExNTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lisata-therapeutics-to-present-at-the-2025-bio-ceo-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lisata Therapeutics to Present at the 2025 BIO CEO &amp; Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=809132"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809132\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=809132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=809132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=809132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}